Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
66 hedge funds and large institutions have $195M invested in Icosavax, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.
144% more call options, than puts
Call options by funds: $78K | Put options by funds: $32K
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
2% more funds holding
Funds holding: 65 → 66 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
25% less capital invested
Capital invested by funds: $258M → $195M (-$63.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.66M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$1.76M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.73M |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$1.3M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$722K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$3.73M |
| 2 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$2.2M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$586K |
| 4 |
BlackRock
New York
|
-$492K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$409K |
ICVX Hedge Fund Activity: Q1 2023 in Review
66 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q1 2023, worth a combined $195M — down 25% from $258M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ICVX positions and 11 closed out — a net gain of 1 holder — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $9.66M. The largest seller was Invesco, exiting entirely with an estimated $3.73M sold.
- 66 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q1 2023, up from 65 in Q4 2022.
- Funds reported $195M of Icosavax, Inc. Common Stock stock for Q1 2023, down 25% quarter-over-quarter.
- 12 funds opened new Icosavax, Inc. Common Stock positions in Q1 2023 and 11 closed out, a net change of +1 holder.
- The largest Icosavax, Inc. Common Stock buyer in Q1 2023 was Fidelity Investments, an estimated $9.66M added.
- The largest Icosavax, Inc. Common Stock seller in Q1 2023 was Invesco, an estimated $3.73M sold.
Based on aggregated 13F filings for Q1 2023.